Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism.

Luisa WeissWido UhrigSarah KelliherPaulina B SzklannaTadhg PrendivilleShane P ComerOsasere EdebiriKarl EganÁine LennonBarry KevaneSean MurphyFionnuala Ní ÁinlePatricia B Maguire

Published in: Proteomics. Clinical applications (2024)

These differences suggest Rivaroxaban may have pleiotropic effects, supporting the reports of its emerging anti-inflammatory and cardiovascular-protective characteristics relative to warfarin.

Keyphrases

venous thromboembolism
direct oral anticoagulants
anti inflammatory
atrial fibrillation
emergency department
adverse drug
pulmonary embolism